Boon or bust? Heidegger, disability aesthetics and the thalidomide memorial

Disability and Society

Volumn 29, Issue 5, 2014, Pages 751-762

  Abrams, Thomas ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

aesthetics; Contergan; Heidegger; thalidomide memorial

Indexed keywords

EID: 84900813728     PISSN: 09687599     EISSN: 13600508     Source Type: Journal    
DOI: 10.1080/09687599.2013.848784     Document Type: Article

References (26)

1. Annas, G., and S. Elias. 1999. "Thalidomide and the Titanic: Reconstructing the Technology Tragedies of the Twentieth Century." American Journal of Public Health 89 (1): 98-101.
2. BBC. 2012. German Thalidomide Maker Gruenenthal Issues Apology. http://www.bbc.co.uk/news/health-19443910
3. Daemmrich, A. 2002. "A Tale of Two Experts: Thalidomide and Political Engagement in the United States and West Germany." Social History of Medicine 15 (1): 137-158.
4. Franks, M. E., G. R. Macpherson, and W. D. Figg. 2004. "Thalidomide." The Lancet 363(9423): 1802-1811.
5. Heidegger, M. 1973. Art and Space. Man and World 6 (1): 3-8.
6. Heidegger, M. 1993a. "On the Essence of Truth." In Martin Heidegger: Basic Writings. 2nd ed, edited by D. F. Krell, 111-138. San Francisco: Harper Collins.
7. Heidegger, M. 1993b. 'The Origin of the Work of Art.' In Martin Heidegger: Basic Writings. 2nd ed, edited by D. F. Krell, 143-212. San Francisco: Harper Collins.
8. Heidegger, M. 1996. Being and Time. (Translated by J. Stambaugh) New York: State University of New York Press.
9. Hughes, B. 1999. "The Constitution of Impairment: Modernity and the Aesthetic of Oppression." Disability & Society 14 (2): 155-172.
10. Hughes, B. 2000. "Medicine and the Aesthetic Invalidation of Disabled People." Disability & Society 15 (4): 555-568.
11. Kämper, O. 2012. Too Little, Too Late, Say Thalidomide Victims. Deutsche Welle. http://www.dw.de/too-little-too-late-say-thalidomide-victims/a-16214497
12. McBride, W. 2004. "Health of Thalidomide Victims and Their Progeny." The Lancet 363 (9043): 169-169.
13. Melchert, M., and A. List. 2007. "The Thalidomide Saga." International Journal of Biochemistry and Cell Biology 39 (7-8): 1489-1499.
14. Oliver, M. 1990. The Politics of Disablement. London: Macmillan.
15. Overboe, J. 1999. "Difference in Itself': Validating Disabled People's Lived Experience." Body & Society 5 (4): 17-29.
16. Schillmeier, M. 2007. Dis/Abling Practices: Rethinking Disability. Human Affairs 17 (2): 195-208.
17. Schillmeier, M. 2008. "Time-Spaces of in/Dependence and Dis/Ability." Time and Society 17 (2/3): 215-231.
18. Schillmeier, M. 2010. Rethinking Disability: Bodies, Senses, Things. New York: Routledge.
19. Siebers, T. 2006. "Disability Aesthetics." Journal for Cultural and Religious Theory 7 (2): 63-73.
20. Siebers, T. 2010. Disability Aesthetics. Ann Arbor: University of Michigan Press.
21. The Thalidomide Trust. 2011. Securing Our Future: The Disability and Health Costs of UK Thalidomide-Affected People. Eaton Scoton: National Advisory Committee to the Thalidomide Trust.
22. Timmermans, S., and V. Leiter. 2000. "The Redemption of Thalidomide: Standardizing the Risk of Birth Defects." Social Studies of Science 30 (1): 41-71.
23. Titchkosky, T. 2000. "Disability Studies: The Old and the New." Canadian Journal of Sociology 25 (2): 197-224.
24. Titchkosky, T. 2007. Reading and Writing Disability Differently: The Textured Life of Embodiment. Toronto: University of Toronto Press.
25. von Moos, R., R. Stolz, T. Cerny, and S. Gillessen. 2003. "Thalidomide: From Tragedy to Promise." Swiss Medical Weekly 133: 77-87.
26. Watson, S. 2006. "Heidegger, Paul Klee, and the Origin of the Work of Art." The Review of Metaphysics 60 (2): 327-357.